India’s Lupin recalls 6,752 bottles of Testosterone topical solution from U.S. – PTI in Econmic Times


The US arm of drug firm LupinNSE 0.97 % is recalling 6,752 bottles of Testosterone Topical solution from the American market on account of defective container, the USFDA said.
The product is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.
Lupin Pharmaceuticals Inc is recalling the 6,752 bottles of Testosterone Topical solution in the strength of 30mg/1.5mL manufactured by Lupin at its Pithampur plant,  ..

Shiwani Sharma

Shiwani Sharma was Senior Editor at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post